These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15807877)

  • 1. Genotypes of the pancreatic beta-cell K-ATP channel and clinical phenotypes of Japanese patients with persistent hyperinsulinaemic hypoglycaemia of infancy.
    Ohkubo K; Nagashima M; Naito Y; Taguchi T; Suita S; Okamoto N; Fujinaga H; Tsumura K; Kikuchi K; Ono J
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):458-65. PubMed ID: 15807877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABCC8 (SUR1) and KCNJ11 (KIR6.2) mutations in persistent hyperinsulinemic hypoglycemia of infancy and evaluation of different therapeutic measures.
    Darendeliler F; Fournet JC; Baş F; Junien C; Gross MS; Bundak R; Saka N; Günöz H
    J Pediatr Endocrinol Metab; 2002; 15(7):993-1000. PubMed ID: 12199344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dominantly acting ABCC8 mutations in patients with medically unresponsive hyperinsulinaemic hypoglycaemia.
    Flanagan SE; Kapoor RR; Banerjee I; Hall C; Smith VV; Hussain K; Ellard S
    Clin Genet; 2011 Jun; 79(6):582-7. PubMed ID: 20573158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of Japanese patients with persistent hyperinsulinemic hypoglycemia of infancy: nucleotide-binding fold-2 mutation impairs cooperative binding of adenine nucleotides to sulfonylurea receptor 1.
    Tanizawa Y; Matsuda K; Matsuo M; Ohta Y; Ochi N; Adachi M; Koga M; Mizuno S; Kajita M; Tanaka Y; Tachibana K; Inoue H; Furukawa S; Amachi T; Ueda K; Oka Y
    Diabetes; 2000 Jan; 49(1):114-20. PubMed ID: 10615958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Congenital hyperinsulinism in newborn and infant].
    Giurgea I; Ribeiro MJ; Boddaert N; Touati G; Robert JJ; Saudubray JM; Jaubert F; Bellanné-Chantelot C; Brunelle F; Nihoul-Fékété C; de Lonlay P
    Arch Pediatr; 2005 Nov; 12(11):1628-35. PubMed ID: 16198094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia.
    Verkarre V; Fournet JC; de Lonlay P; Gross-Morand MS; Devillers M; Rahier J; Brunelle F; Robert JJ; Nihoul-Fékété C; Saudubray JM; Junien C
    J Clin Invest; 1998 Oct; 102(7):1286-91. PubMed ID: 9769320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diazoxide-unresponsive congenital hyperinsulinism in children with dominant mutations of the β-cell sulfonylurea receptor SUR1.
    Macmullen CM; Zhou Q; Snider KE; Tewson PH; Becker SA; Aziz AR; Ganguly A; Shyng SL; Stanley CA
    Diabetes; 2011 Jun; 60(6):1797-804. PubMed ID: 21536946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial ABCC8 gene deletion mutations causing diazoxide-unresponsive hyperinsulinaemic hypoglycaemia.
    Flanagan S; Damhuis A; Banerjee I; Rokicki D; Jefferies C; Kapoor R; Hussain K; Ellard S
    Pediatr Diabetes; 2012 May; 13(3):285-9. PubMed ID: 21978130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A point mutation inactivating the sulfonylurea receptor causes the severe form of persistent hyperinsulinemic hypoglycemia of infancy in Finland.
    Otonkoski T; Ammälä C; Huopio H; Cote GJ; Chapman J; Cosgrove K; Ashfield R; Huang E; Komulainen J; Ashcroft FM; Dunne MJ; Kere J; Thomas PM
    Diabetes; 1999 Feb; 48(2):408-15. PubMed ID: 10334322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperinsulinism of infancy: novel ABCC8 and KCNJ11 mutations and evidence for additional locus heterogeneity.
    Tornovsky S; Crane A; Cosgrove KE; Hussain K; Lavie J; Heyman M; Nesher Y; Kuchinski N; Ben-Shushan E; Shatz O; Nahari E; Potikha T; Zangen D; Tenenbaum-Rakover Y; de Vries L; Argente J; Gracia R; Landau H; Eliakim A; Lindley K; Dunne MJ; Aguilar-Bryan L; Glaser B
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6224-34. PubMed ID: 15579781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1.
    Huopio H; Reimann F; Ashfield R; Komulainen J; Lenko HL; Rahier J; Vauhkonen I; Kere J; Laakso M; Ashcroft F; Otonkoski T
    J Clin Invest; 2000 Oct; 106(7):897-906. PubMed ID: 11018078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of ABCC8 and KCNJ11 gene mutations and phenotypes in Korean patients with congenital hyperinsulinism.
    Park SE; Flanagan SE; Hussain K; Ellard S; Shin CH; Yang SW
    Eur J Endocrinol; 2011 Jun; 164(6):919-26. PubMed ID: 21422196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of genes encoding the pancreatic beta-cell ATP-sensitive K+ channel in persistent hyperinsulinemic hypoglycemia of infancy in Japanese patients.
    Someya T; Miki T; Sugihara S; Minagawa M; Yasuda T; Kohno Y; Seino S
    Endocr J; 2000 Dec; 47(6):715-22. PubMed ID: 11228046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analyses of novel mutations in the sulfonylurea receptor 1 associated with persistent hyperinsulinemic hypoglycemia of infancy.
    Shyng SL; Ferrigni T; Shepard JB; Nestorowicz A; Glaser B; Permutt MA; Nichols CG
    Diabetes; 1998 Jul; 47(7):1145-51. PubMed ID: 9648840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinism.
    Bellanné-Chantelot C; Saint-Martin C; Ribeiro MJ; Vaury C; Verkarre V; Arnoux JB; Valayannopoulos V; Gobrecht S; Sempoux C; Rahier J; Fournet JC; Jaubert F; Aigrain Y; Nihoul-Fékété C; de Lonlay P
    J Med Genet; 2010 Nov; 47(11):752-9. PubMed ID: 20685672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations.
    Pinney SE; MacMullen C; Becker S; Lin YW; Hanna C; Thornton P; Ganguly A; Shyng SL; Stanley CA
    J Clin Invest; 2008 Aug; 118(8):2877-86. PubMed ID: 18596924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of neonatal hyperinsulinism.
    Giurgea I; Bellanné-Chantelot C; Ribeiro M; Hubert L; Sempoux C; Robert JJ; Blankenstein O; Hussain K; Brunelle F; Nihoul-Fékété C; Rahier J; Jaubert F; de Lonlay P
    Horm Res; 2006; 66(6):289-96. PubMed ID: 17003566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spectrum of ABCC8 mutations in Norwegian patients with congenital hyperinsulinism of infancy.
    Sandal T; Laborie LB; Brusgaard K; Eide SA; Christesen HB; Søvik O; Njølstad PR; Molven A
    Clin Genet; 2009 May; 75(5):440-8. PubMed ID: 19475716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.
    Babenko AP; Polak M; Cavé H; Busiah K; Czernichow P; Scharfmann R; Bryan J; Aguilar-Bryan L; Vaxillaire M; Froguel P
    N Engl J Med; 2006 Aug; 355(5):456-66. PubMed ID: 16885549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of imprinted genes and paternal SUR1 mutations lead to hyperinsulinism in focal adenomatous hyperplasia.
    Fournet JC; Verkarre V; De Lonlay P; Rahier J; Brunelle F; Robert JJ; Nihoul-Fékété C; Saudubray JM; Junien C
    Ann Endocrinol (Paris); 1998; 59(6):485-91. PubMed ID: 10189991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.